| 000 | 01700 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513125151.0 | ||
| 264 | 0 | _c19980421 | |
| 008 | 199804s 0 0 eng d | ||
| 022 | _a0929-7855 | ||
| 024 | 7 |
_a10.1016/s0929-7855(97)00019-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBalsa, D | |
| 245 | 0 | 0 |
_aEffect of endotoxin and platelet-activating factor on rat vascular permeability: role of vasoactive mediators. _h[electronic resource] |
| 260 |
_bJournal of lipid mediators and cell signalling _cSep 1997 |
||
| 300 |
_a31-45 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xpharmacology |
| 650 | 0 | 4 |
_aBlood Proteins _xmetabolism |
| 650 | 0 | 4 |
_aCapillary Permeability _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aExudates and Transudates _xdrug effects |
| 650 | 0 | 4 |
_aImidazoles _xpharmacology |
| 650 | 0 | 4 |
_aIndomethacin _xpharmacology |
| 650 | 0 | 4 |
_aLeucine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aLipopolysaccharides _xadministration & dosage |
| 650 | 0 | 4 |
_aLipoxygenase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPiperazines _xpharmacology |
| 650 | 0 | 4 |
_aPlatelet Activating Factor _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPyrazoles _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 700 | 1 | _aMerlos, M | |
| 700 | 1 | _aGiral, M | |
| 700 | 1 | _aFerrando, R | |
| 700 | 1 | _aGarcia-Rafanell, J | |
| 700 | 1 | _aForn, J | |
| 773 | 0 |
_tJournal of lipid mediators and cell signalling _gvol. 17 _gno. 1 _gp. 31-45 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0929-7855(97)00019-9 _zAvailable from publisher's website |
| 999 |
_c9280971 _d9280971 |
||